What Is the Learning Curve for Carotid Artery Stenting With Neuroprotection? Analysis of 200 Consecutive Cases at an Academic Institution

Abstract

Carotid artery stenting (CAS) has emerged as an acceptable treatment alternative in high-risk patients with carotid stenosis. This study assessed the effect of the Learning curve on treatment complications and clinical outcome of CAS. Clinical variables and treatment outcomes of 200 consecutive CAS procedures in 182 patients (mean age, 72 years) with carotid stenosis of 70% or greater during a 40-month period were analyzed. Technical success, periprocedural complications, and treatment outcomes were compared in four sequential groups (group 1 1I, Ill, and IV) of 50 consecutive interventions. Treatment indications and relevant risk factors were similar among the four groups. The overall technical success was 98%, and the combined 30-day stroke and death rates was 2.5%. An increase in the technical success rate was noted in the latter three groups compared with group I (P < .05). Total procedural time and contrast volume were significantly higher in group I compared with the latter three groups (P < .05). The intraoperative anticoagulation regimen was changed from an intravenous heparin combination to bivalirudin after the first 54 cases, resulting in reduced bleeding complications in groups Ill and IV (P = .03) compared with group 1. The 30-day stroke and death rate in groups I and 11 was 8% and 2%, which was reduced significantly to 0% in groups Ill and IV (P < .05). A Cox regression model identified procedural volume (P = .03) as a predictor of a reduced complication rate. Carotid artery stenting with neuroprotection can provide excellent treatment outcome. Our experience demonstrates a procedural-associated learning curve, as evidenced by the reduced procedural-related complications, fluoroscopic time, and contrast volume that occurred with an increase in physician experience. The procedural success is also enhanced partly by endovascular device refinement and improved anticoagulation regimen. Successful outcome of CAS can be achieved once physicians overcome the initial procedural-related learning curve.

Keywords

carotid artery stenting procedural-related learning curve neuroprotection devices

Get full access to this article

View all access options for this article.

References

1. Becquemin JP , Ben El Kadi H , Desgranges P ., et al: Carotid stenting versus carotid surgery: a prospective cohort study. J Endovasc Ther 10:687-694, 2003.

2. CARESS Steering Committee : Carotid revascularization uising endarterectomy or stenting systems (CA-RESS): phase I clinical trial. J Endovasc Ther 10:021-1030, 2003.

3. Brooks WH , McClure RR , Jones MR , et al: Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosuirgery 54: 318-324; discussion 324-315, 2004.

4. Yadav JS : Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Med 71 (suppl 1): S45-46, 2004.

5. Yadav JS , Wholey MH , Kuntz RE , et al: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493-1501, 2004.

6. Kerber CW , Cromwell LD , Loehden OL : Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1:348-349, 1980.

7. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Veitebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357:1729-1737. 2001.

8. Hobson RW 2nd : Status of carotid angioplasty and stenting trials. J Vasc Surg 27:791-791, 1998.

9. Veith FJ , Amor M , Ohki T , et al: Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders.,JVasc Surg 33:S111-116, 2001.

10.

10. Lin PIJ , Bush RL , Lumsden AB : Carotid artery stenting: current status and future directions. Vasc Endovascular Surg 37:315-322, 2003.

11.

11. Lin PH , Bush RL , Lubbe DF , et al: Carotid artery stenting with routine cerebral protection in high-risk patients. Am J Surg 188:644-652, 2004.

12.

12. Bush RL , Bhama JK , Liin PH :. Transient ischemic attack due to early carotid stent thrombosis: successful rescue with rheolytic thrombectomy and systemic ab-ciximab. J Endovasc Ther 10:870-874, 2003

13.

13. Alberts MJ , McCann R , Smith TP : A randomized trial: carotid stenting versus endarterectomy in patients with symptomatic carotid stenosis, study designs. J Neurovasc Dis Nouseihbei--)ecembet-:228-234 1997.

14.

14. Alberts MJ : Restilts of a mtilticenter prospective randomized trial of carotid artery stenting vs. carotid endarterectomy. Stroke 32:325-325, 2001.

15.

15. Wholey MH , Al-Mubarek N : Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 60:259-266, 2003.

16.

16. Wholey MII , Wholey M , Mathias K , et al: Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv; 50:160-167, 2000.

17.

17. Naylor AR , Bolia A , Abbott RJ , et al: Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 28:326-334, 1998.

18.

18. Ahmadi R . Willfort A , I ang W . et al: Caiotid artery stenting: effect of learning curve and ititermediateteim morphological outcome. J Endovasc Thet 8:539-546, 2001.

19.

19. Diethrich EB , Ndiaye M , Reid DB . Stenting in the carotid artery: initial experie Tice in 110 patients. J Endovasc Surg 3:42-62, 1996.

20.

20. New G , Roubin GS , Iyer SS , Vitek JJ . Carotid artery stenting: rationale, indications, and results. Compr Ther 25:438-445, 1999.

21.

21. Roubin GS , New G , lyer SS , et al: Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 103:532-537, 2001. mio et a C(AS Learainog Curve 123

22.

22. Barr JD , Connoros JJ 3r d . Sacks 1), et al: Qualitv improvement guidelines for rhe performance of cervi cal. carotid angioplasty and stent placeiment. J Vase Ilnterv Radiol 14:S321-S335, 2003.

23.

23. Barr JD , Connors JJ 3rd , Sacks D , et al: Quality im-proverne-o guidelines for Lhe perflormance of cervical carotid angioplasty and stent placemet. AJNR Am J Neuroradiol 24:2020-2034t 2003.

24.

24. Rosenfield KM . Clinical competence statement on carotid stenting: training and credentialing for carotid stenting-----multispecialty consensus recommendatinos. J Vase Surg 41:160-163, 2005.

25.

25. Roseolnield K , Babb JD , Cates CU , et al: Clinical cOIn-petence statemint on carotid stenting: training and ciedentialing for carotid stenting-ntultispecialty consensus reconmein(ldations: a report of the SCAI'/SVMB/SVS Writing Comimittee to develop a clioical competence statement o0 carotid in-terven-lions. J Am Coll Cardiol 45:165-174. 2005.

26.

26. Rosenfield K : Clinical competence statement on carotid sienting: training arid credenoialing for carotid stentiog mutltispecialty consensus recoin-mendations Catheter Cardiovasc Inteiv 64:1-11, 2005.

27.

27. Hsu. H , Younao D ), Paodalai S et al: Use of COmputer simtlation for deterimining endovascular skill levels in a carotid stenting model. J Vasc Surg 40 1118-1125, 2004.

28.

28. Dayal R , Fanries Pl , Lin SC , et al: Compruter simulation as a component of catheter-based trainiog. J Vasc Sutrg 40:1112-1117, 2004.

29.

29. Gallagher AG , Cates CU : Approval i fvirtual reality training for carotid stenting: what this means foir procedural-based Medicinte. JAMA 292:3024-3026, 2004.

30.

30. Lincoff AM , Bittl JA ., Kleitan NS , et al:Cormparison of bivalirudin versus heparin during percutaoieous coronary intervation (the Randomized valuaronti of PCI Linking Angioniax to Reduced Clinical Events [REPlACE]-1 trial). Am J Cafrdiol 93:1092-1096. 2004.

31.

31. Lincoff AM , Kleiman NS , KIeiciakes DJ , et al: Icong-term efficacv of bivalirudin aod provisiconal glvco-protein IHb/fia blockade vs heparin and planned gly-coprotein 1b1lIl. a block-ade during perciaLIIreous coronary revascularizaioon: REPLACE-2 randomized trial. JAMA 292:696-703, 2004.